1-hexyl-1,4-diazabicyclo[2.2.2]octan-1-ium iodide

Catalog No.: 
ACRPBD017
CAS No.: 
1009321-13-4
Molecular Formula: 
C12H25N2.HI
Molecular Weight: 
324.11
1-hexyl-1,4-diazabicyclo[2.2.2]octan-1-ium iodide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%
25g95%
100g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-hexyl-1,4-diazabicyclo[2.2.2]octan-1-ium iodide
IUPAC Name1-hexyl-1,4-diazabicyclo[2.2.2]octan-1-ium iodide
MDL No.MFCD32880076
Molecular FormulaC12H25N2.HI
Molecular Weight324.11
SMILESCCCCCC[N+]1(CC2)CCN2CC1.[I-]
InChI KeyYWXJUXGXGOWSCJ-UHFFFAOYSA-M
SynonymH1759 | 1-hexyl-4-aza-1-azoniabicyclo[2.2.2]octane;iodide | 1009321-13-4 | 1-Hexyl-1,4-diazabicyclo[2.2.2]octan-1-ium iodide | starbld0016275 | MFCD32880076
CAS No.1009321-13-4
PubChem CID155897203

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRPBD017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBYQG094 route compound structure diagram
    ACBYQG09454581-69-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPBD017 route product structure diagram
    ACRPBD0171009321-13-4In Stock
Inquiry

2. ACRPBD017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBYQG094 route compound structure diagram
    ACBYQG09454581-69-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPBD017 route product structure diagram
    ACRPBD0171009321-13-4In Stock
Inquiry

3. ACRPBD017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRPBD017 route product structure diagram
    ACRPBD0171009321-13-4In Stock
Inquiry

Comments (0)